Clinical trial
Cathflo Activase Pediatric Study
NCT00307580 · Genentech, Inc., Industry · Completed
Key facts
| NCT number | NCT00307580 |
|---|---|
| Title | Cathflo Activase Pediatric Study |
| Official title | Cathflo Activase (Alteplase) Pediatric Study (CAPS) |
| Lead sponsor | Genentech, Inc., Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Dysfunctional Central Venous Access Devices (CVADS) |
| Intervention type | Drug |
| Interventions | Cathflo Activase (Alteplase) |
| Enrollment | 300 |
| Start date | Apr 1, 2002 |
| Completion | May 1, 2003 |
| First posted | Mar 28, 2006 |
| Last update posted | Apr 9, 2014 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: